Simple oral direct-acting antiviral treatment for hepatitis C virus (HCV) infection has transformed clinical management and paved the way for elimination.1 The first pan-genotypic fixed-dose ...

An 8-week bemnifosbuvir-ruzasvir regimen leads to a sustained virologic response in 90% of treated patients with hepatitis C ...

As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing ...

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Hepatitis C is inflammation of the liver in humans caused by the hepatitis C virus. The virus is primarily transmitted by blood-to-blood contact associated with transfusion and intravenous drug use.

As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing ...

Uncover the latest and most impactful research in Hepatitis C Virus Infection Dynamics and Treatment Approaches. Explore pioneering discoveries, insightful ideas and new methods from leading ...

A new Burnet Institute study finds that introducing a hepatitis C outreach and treatment program in Australian community pharmacies, particularly those offering opioid agonist therapy, could ...

October 20 is Liver Day, designated by the Korean Liver Foundation and the Korean Association for the Study of the Liver.

A study led by Megan Curtis, MD, an assistant professor in the Division of Infectious Diseases at WashU Medicine (right), and Caroline Cary, a third-year medical student, showed that recently pregnant ...